NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

The effect of time and temperature variables on routine coagulation tests.

Author(s): Adcock D, Kressin D, Marlar RA

Publication: Blood Coagul Fibrinolysis, 1998, Vol. 9, Page 463-70

PubMed ID: 9818995 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of oral anticoagulant therapy and storage of blood or plasma on prothrombin time (PT) and activated partial thromboplastin time (APTT) in normal subjects and hospitalized patients.

Conclusion of Paper

PT changed less than 10% after storage of whole blood or plasma at room temperature or on ice for up to 24 h. APTT increased steadily with time in specimens from healthy subjects and hospital patients not receiving unfractionated heparin, but most changes were less than 10% until 8 h and no consistent effects of storage temperature were found. In patients receiving unfractionated heparin, APTT decreased rapidly with storage of whole blood but decreased only slightly when plasma was stored. In conclusion, blood and plasma specimens from patients not receiving heparin may be stored at 4 degrees C or room temperature for up to 8 h prior to analysis, but for patients receiving heparin, specimens must be centrifuged within 1 h at room temperature or within 4 h at 4 degrees C.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of oral anticoagulant therapy and storage of blood or plasma at room temperature or on ice on PT and APTT in normal subjects and hospitalized patients.

    Summary of Findings:

    PT changed less than 10% after storage of whole blood or plasma at room temperature or on ice for up to 24 h. APTT increased steadily over the 24 h period in specimens from healthy subjects (8.3-16.7%), and hospital patients not receiving unfractionated heparin (9.6-12.6%), but most changes were less than 10% until 8 h and no consistent effects of storage temperature were found. In patients receiving unfractionated heparin, APTT decreased rapidly over the 24 h period when stored as whole blood (33.1-35.6%) but decreased only slightly when plasma was stored (4.4-10.6%). Importantly, the effect of whole blood storage at room temperature in patients receiving unfractionated heparin could be observed as early as 2 h, but no effect was seen until at least 4 h when whole blood specimens were stored on ice. In conclusion, blood and plasma specimens from patients not receiving heparin may be stored at 4 degrees C or room temperature for up to 8 h prior to analysis, but for patients receiving heparin, specimens must be centrifuged within 1 h at room temperature or within 4 h at 4 degrees C.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Normal
    • Other diagnoses
    Platform:
    AnalyteTechnology Platform
    Morphology Hematology/ auto analyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Preaquisition Other drugs No anticoagulant therapy
    Coumadin
    Unfractionated heparin
    Preaquisition Diagnosis/ patient condition Normal
    Hospitalized patient
    Storage Storage temperature On ice
    Room temperature
    Storage Storage duration Less than 1 h
    4 h
    6 h
    8 h
    24 h
    Biospecimen Aliquots and Components Blood and blood products Plasma
    Whole blood
    Biospecimen Aliquots and Components Centrifugation Centrifugation delays investigated

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...